Loading...

Brilliant Violet 510™ anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30F11_BV510_CD45_Antibody_FC_083112
C57BL/6 mouse splenocytes were stained with CD45 (clone 30-F11) Brilliant Violet 510™.
  • 30F11_BV510_CD45_Antibody_FC_083112
    C57BL/6 mouse splenocytes were stained with CD45 (clone 30-F11) Brilliant Violet 510™.
See Brilliant Violet 510™ spectral data
Cat # Size Price Quantity Check Availability Save
103137 125 µL 146€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103138 50 µg 194€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 510™ under optimal conditions.
Concentration
µg sizes: 0.2 mg/mL
µL sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining using the µg size, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. For immunofluorescent staining using the µl size, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 510™ excites at 405 nm and emits at 510 nm. The bandpass filter 510/50 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 510™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Thiriot A et al. 2017. BMC biology. 15(1):45 . PubMed
  2. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  3. Halim TYF et al. 2018. Immunity. 48(6):1195-1207 . PubMed
  4. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  5. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  6. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  7. Linehan JL et al. 2018. Cell. 172(4):784-796 . PubMed
  8. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  9. Jacobson A et al. 2018. Cell host & microbe. 24(2):296-307 . PubMed
  10. Scott CL et al. 2018. Immunity. 49(2):312-325 . PubMed
  11. Casulli J, et al. 2019. Nat Commun. 10:2121. PubMed
  12. Lancaster JN, et al. 2019. Nat Commun. 10:2220. PubMed
  13. Weinstock A, et al. 2019. Immunometabolism. 1. PubMed
  14. Xiao Y, et al. 2018. Int Immunol. 30:457. PubMed
  15. Duc D et al. 2019. Cell Rep. 29(2):378-390 . PubMed
  16. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  17. Thanabalasuriar A et al. 2019. Cell Host Microbe. 25(4):526-536 . PubMed
  18. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  19. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  20. Silva DA, et al. 2019. Nature. 565:186. PubMed
  21. Bonnardel J, et al. 2019. Immunity. 51:638. PubMed
  22. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  23. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  24. Hiraishi Y, et al. 2018. Sci Rep. 8:18052. PubMed
  25. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  26. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  27. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  28. Sfakianos JP, et al. 2020. Nat Commun. 2.222222222. PubMed
  29. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  30. Jordan S, et al. 2020. Cell. 178(5):1102-1114.e17.. PubMed
  31. Nagai M, et al. 2020. Cell. 178(5):1072-1087.e14.. PubMed
  32. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  33. Cuff AO, et al. 2020. Frontiers in Immunology. 1.930555556. PubMed
  34. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  35. Taguchi K, et al. 2014. J Am Soc Nephrol. 25:1680. PubMed
  36. Holm J, et al. 2015. PLoS One. 10:125495. PubMed
  37. Taguchi K, et al. 2015. J Urol. . PubMed
  38. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  39. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  40. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  41. LM S, et al. 2016. Cell Rep. 16(12): 3286-96. PubMed
  42. Tian Y, et al. 2020. JCI Insight. 5:00. PubMed
  43. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  44. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  45. Li JY, et al. 2020. J Clin Invest. 130:1767. PubMed
  46. Benitez AA, et al. 2020. Commun Biol. 0.371527778. PubMed
  47. Cornax I, et al. 2021. Microorganisms. 9:00. PubMed
  48. Upadhyaya P, et al. 2021. J Immunother Cancer. 9:00. PubMed
  49. Tyagi AM, et al. 2021. eLife. 10:00. PubMed
  50. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  51. LaMarche NM, et al. 2020. Cell Metabolism. 32(2):243-258.e6. PubMed
  52. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  53. Neupane AS, et al. 2020. Cell. 183(1):110-125.e11. PubMed
  54. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
  55. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  56. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  57. Huang X, et al. 2020. Cell Host Microbe. 29(2):210-221.e6. PubMed
  58. Stacy A, et al. 2021. Cell. 184(3):615-627.e17. PubMed
  59. Xia L, et al. 2021. Cell Chemical Biology. 28(5):610-624.e5. PubMed
  60. Dang MT, et al. 2021. Cell Reports. 34(13):108917. PubMed
  61. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  62. Dikiy S, et al. 2021. Immunity. 54(5):931-946.e11. PubMed
  63. Dewi IMW, et al. 2021. Cell Reports Medicine. 2(5):100289. PubMed
  64. Dong L, et al. 2021. Cancer Cell. . PubMed
  65. Wang X, et al. 2021. Immunity. 54(6):1123-1136.e8. PubMed
  66. Lima-Junior DS, et al. 2021. Cell. . PubMed
  67. Louka E, et al. 2021. Journal of Experimental Medicine. 218(2):. PubMed
  68. Pandey V, et al. 2021. eLife. 0.416666666666667. PubMed
  69. Wang Y, et al. 2021. Cancer Cell. 39:1375. PubMed
  70. Montalban-Arques A, et al. 2021. Cell Host Microbe. :. PubMed
  71. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  72. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  73. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  74. Yoshihara E, et al. 2020. Nature. 606:586. PubMed
  75. Pan XX, et al. 2021. Front Cell Dev Biol. 637424:9. PubMed
  76. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  77. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  78. Xu Y, et al. 2021. Stem Cell Res Ther. 12:112. PubMed
  79. Li X, et al. 2021. Front Cell Dev Biol. 9:647713. PubMed
  80. Wang H, et al. 2021. Malar J. 20:249. PubMed
  81. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  82. Carlson PM, et al. 2021. J Immunol. 207:720. PubMed
  83. Panea C, et al. 2021. Commun Biol. 4:913. PubMed
  84. Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
  85. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  86. Ayari A, et al. 2020. Commun Biol. 3:237. PubMed
  87. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  88. Devalaraja S, et al. 2020. STAR Protoc. 1:100188. PubMed
  89. Yu M, et al. 2021. J Clin Invest. 131:. PubMed
  90. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  91. Tripathi A, et al. 2021. Mol Psychiatry. 26:3043. PubMed
  92. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  93. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  94. Jiang M, et al. 2021. Front Pharmacol. 12:657486. PubMed
  95. Zhang XW, et al. 2021. Oncoimmunology. 10:1920739. PubMed
  96. Alam J, et al. 2021. Front Immunol. 12:701415. PubMed
  97. Afolabi LO, et al. 2021. Front Immunol. 12:701671. PubMed
  98. Poli V, et al. 2021. iScience. 24:103256. PubMed
  99. Dang MT, et al. 2021. STAR Protoc. 2:100957. PubMed
  100. Boal-Carvalho I, et al. 2020. EMBO Rep. 21:e50421. PubMed
  101. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  102. Catrysse L, et al. 2021. Cell Rep. 36:109748. PubMed
  103. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  104. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  105. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  106. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  107. Espinal A, et al. 2022. Int J Mol Sci. 23:. PubMed
  108. Xu JL, et al. 2022. Front Pharmacol. 13:911663. PubMed
  109. Kalavska K, et al. 2021. Int J Mol Sci. 22:. PubMed
  110. Zamarin D, et al. 2020. Clin Cancer Res. 26:4531. PubMed
  111. Leslie J, et al. 2021. Sci Rep. 11:1415. PubMed
  112. Smith LK, et al. 2021. Elife. 10:. PubMed
  113. Guilliams M, et al. 2022. Cell. 185:379. PubMed
  114. Domanska D, et al. 2022. J Exp Med. 219:. PubMed
  115. Liu J, et al. 2022. Nat Commun. 13:4308. PubMed
  116. Wang L, et al. 2022. Cancer Res Commun. 2:518. PubMed
  117. Sun Q, et al. 2022. Cell Death Dis. 13:724. PubMed
  118. Seki N, et al. 2022. iScience. 25:104838. PubMed
  119. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  120. Silver J, et al. 2020. Methods Mol Biol. 2121:115. PubMed
  121. Matsumoto R, et al. 2021. Front Pharmacol. 12:715752. PubMed
  122. Figueiredo CA, et al. 2022. J Neuroinflammation. 19:17. PubMed
  123. Kalavska K, et al. 2022. Front Oncol. 12:858797. PubMed
  124. Alam J, et al. 2022. Mucosal Immunol. 15:620. PubMed
  125. Aulova KS, et al. 2022. Molecules. 27:. PubMed
  126. Mackel JJ, et al. 2022. Front Cell Infect Microbiol. 12:974175. PubMed
  127. Gawish R, et al. 2022. Elife. 11:. PubMed
  128. Yang P, et al. 2022. Nat Commun. 13:5782. PubMed
  129. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  130. Chen H, et al. 2022. Mol Ther Methods Clin Dev. 27:431. PubMed
  131. Denny L, et al. 2021. Clin Transl Immunology. 10:e1234. PubMed
  132. Li DD, et al. 2022. J Cell Mol Med. 26:2438. PubMed
  133. Agarwalla P, et al. 2022. Nat Biotechnol. 40:1250. PubMed
  134. Yang Z, et al. 2022. Cancer Discov. 12:1942. PubMed
  135. Garnier L, et al. 2022. Sci Adv. 8:eabl5162. PubMed
  136. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  137. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  138. Caslin HL, et al. 2023. Front Immunol. 13:984859. PubMed
  139. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  140. Abu Hejleh AP, et al. 2023. Int J Tryptophan Res. 16:11786469231153111. PubMed
  141. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  142. Allen SD, et al. 2021. Biomaterials. 269:120635. PubMed
  143. Dube CT, et al. 2022. Epigenetics. 17:444. PubMed
  144. Xu J, et al. 2022. Dev Cell. 57:839. PubMed
  145. Hentzschel F, et al. 2022. Sci Adv. 8:eabm7348. PubMed
  146. Kalavska K, et al. 2022. Life (Basel). 12:. PubMed
  147. Michalek S, et al. 2022. EMBO Rep. 23:e54195. PubMed
  148. Jowett GM, et al. 2022. Cell Rep. 40:111281. PubMed
  149. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  150. Olofsen PA, et al. 2022. Cells. 11:. PubMed
  151. Matter AL, et al. 2022. J Immunol. 209:1880. PubMed
  152. Chen X, et al. 2023. Adv Mater. 35:e2210440. PubMed
  153. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  154. Chen R, et al. 2023. Acta Pharm Sin B. 13:128. PubMed
  155. Li X, et al. 2023. J Clin Invest. 133:. PubMed
  156. Veras FP, et al. 2023. Respir Res. 24:66. PubMed
  157. Vaillancourt M, et al. 2023. PLoS Pathog. 19:e1010942. PubMed
  158. Solier S, et al. 2023. Nature. 617:386. PubMed
  159. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  160. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  161. Pitzer Mutchler A, et al. 2023. Front Physiol. 14:1167904. PubMed
  162. Distel JS, et al. 2023. PLoS Pathog. 19:e1011173. PubMed
RRID
AB_2561392 (BioLegend Cat. No. 103137)
AB_2563061 (BioLegend Cat. No. 103138)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org
Go To Top Version: 2    Revision Date: 05-14-2013

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account